Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Global Medical REIT ( (XRN) ) just unveiled an announcement.
On March 11, 2026, Chiron Real Estate Inc. filed supplementary charter documents in Maryland to classify an additional 3,000,000 shares as 8.00% Series B Cumulative Redeemable Preferred Stock, lifting its total authorization to 5,300,000 preferred shares, and amended its operating partnership agreement to permit a matching increase in economically equivalent Series B preferred units. The company plans to contribute net proceeds from future preferred stock issuances to its operating partnership, reinforcing the REIT’s capital structure and aligning cash flows between the parent and partnership.
On March 12, 2026, Chiron Real Estate Inc. amended and restated its at-the-market common stock offering program, reflecting its new corporate name and adding Huntington Securities and Raymond James as additional agents, forward sellers and forward purchasers, with about $288 million of common shares remaining available for sale or forward transactions. The company simultaneously launched a new at-the-market program for up to $75 million of Series B preferred stock, expanding its equity-raising flexibility through both spot and forward issuances, which may affect future dilution, leverage and income securities available to investors.
The most recent analyst rating on (XRN) stock is a Hold with a $37.00 price target. To see the full list of analyst forecasts on Global Medical REIT stock, see the XRN Stock Forecast page.
Spark’s Take on XRN Stock
According to Spark, TipRanks’ AI Analyst, XRN is a Neutral.
The score is primarily held back by weaker financial performance—2025 net loss, higher leverage, and frequently negative free cash flow—despite steady operating cash generation. Offsetting this are neutral-to-mildly positive technicals, a very high dividend yield, and a generally constructive earnings update with forward FFO guidance and improved near-term debt maturity profile, albeit with notable execution and tenant risks.
To see Spark’s full report on XRN stock, click here.
More about Global Medical REIT
Chiron Real Estate Inc., formerly Global Medical REIT Inc., is a Maryland-based real estate investment trust that owns and manages healthcare-related and other real estate assets. The company accesses capital markets through common and preferred stock offerings on the New York Stock Exchange, using at-the-market programs and forward sale agreements to fund its growth and portfolio investments.
Average Trading Volume: 104,668
Technical Sentiment Signal: Sell
Current Market Cap: $493.5M
Learn more about XRN stock on TipRanks’ Stock Analysis page.